Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$30.15 – $33.66
100% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $717.6M | $761.2M | $836.2M | $1.03B | $1.12B | $1.19B | $1.15B | $1.21B |
| Cost of revenue | $421.8M | $489.6M | $554.5M | $741.3M | $780.7M | $182.6M | $188.8M | $984.8M |
| Gross profit | $295.8M | $247.7M | $281.7M | $286.6M | $342.9M | $1.01B | $965.1M | $227.8M |
| Gross margin | 41.2% | 32.5% | 33.7% | 27.9% | 30.5% | 84.6% | 83.6% | 18.8% |
| R&D | $42.9M | $58.6M | $76.4M | $94.3M | $12.6M | $26.6M | $0 | $274.0M |
| Operating income | $138.3M | $219.2M | $136.7M | $123.3M | $126.0M | $122.9M | $105.7M | $91.5M |
| EBITDA | $182.2M | $142.3M | $194.3M | $202.1M | $219.4M | $193.4M | $206.9M | $198.1M |
| Net income | $96.2M | $65.1M | $59.7M | $60.8M | $68.2M | $41.7M | $34.6M | $28.2M |
| Net margin | 13.4% | 8.5% | 7.1% | 5.9% | 6.1% | 3.5% | 3.0% | 2.3% |
| EPS (diluted) | 1.93 | 1.31 | 1.36 | 1.31 | 1.39 | 0.88 | 0.67 | 0.54 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $1.4B | $2.15 | $2.15–$2.15 | 1 |
| 2027 | $1.4B | $2.47 | $2.47–$2.47 | 1 |
Forward consensus · source: Financial Modeling Prep
COMPUGOUP MED SE
No one on the platform currently holds CMPVF.
No tracked institution reports a position in CMPVF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-04-21 | $0.5000 | 2026-04-22 |
| 2025-08-05 | $0.0500 | 2025-08-06 |
| 2024-05-23 | $1.0000 | 2024-05-27 |
No one on the platform has traded CMPVF yet.
| $1.8B |
| — |
| KKPCFKaken Pharmaceutical Co., Ltd. | $26.00 | +0.00% | $985M | — |
| KSRBFKossan Rubber Industries Bhd | $0.33 | +0.00% | $840M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.